Styker is the latest company to withdraw its first quarter and full-year 2020 financial projections due to the COVID-19 pandemic, according to a March 31 filing on EDGAR.
Spinal Tech
Nexxt Spine on March 31 launched its Matrixx corpectomy system for spine surgery.
Smith+Nephew withdrew its full year 2020 guidance due to the COVDI-19 pandemic.
The FDA granted OrthoPediatrics 510(k) clearance to expand its Response Scoliosis system to include neuromuscular implants on March 31.
Medtronic and DePuy Synthes representatives told the Times Union Online about measures they've implemented to protect local employees and support healthcare providers during the COVID-19 pandemic.
Advertisement
Novartis CEO Vas Narasimhan said on March 29 that his company's hydroxychloroquine drug for malaria, lupus and arthritis is their biggest hope for tackling the coronavirus.
Medtronic is publicly sharing its ventilation design specifications to accelerate global ventilator production efforts during the COVID-19 pandemic, according to a March 30 announcement.
OrthoPeditriacs on March 30 withdrew its 2020 revenue projections that estimated growth within the range of 22 percent to 24 percent.
Medtronic is introducing two online platforms for at-home COVID-19 symptom monitoring and support, the device company announced March 27.
The FDA granted 510(k) clearance to 13 spine devices last month.